Surface Oncology Inc reports results for the quarter ended in September - Earnings Summary

Surface Oncology

02/11/2022 12:11

* Surface Oncology Inc  SURF.OQ  reported a quarterly
adjusted
loss of 39 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 47 cents per share.
    * Reported revenue was zero​; analysts expected $80.00
thousand. 
    * Surface Oncology Inc's reported EPS for the quarter was a
loss
of 39 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Surface Oncology Inc shares had risen by 29.8% this
quarter and
lost 71.8% so far this year.
    * The company reported a quarterly loss of $23.24 million.
    * Wall Street's median 12-month price target for Surface
Oncology
Inc is $12.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
2 at 12:10 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.47          -0.39          Beat
 Jun. 30 2022      -0.46          -0.46          Met
 Mar. 31 2022      -0.28          0.13           Beat
 Dec. 31 2021      -0.15          -0.52          Missed